Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Woodcock VK"'
Autor:
Woodcock, VK, Chen, J-L, Purshouse, K, Butcher, C, Collins, L, Haddon, C, Verrall, G, Elhussein, L, Roberts, C, Tarlton, A, Rei, M, Napolitani, G, Salio, M, Middleton, MR, Cerundolo, V, Crew, J, Protheroe, AS
Publikováno v:
BJUI Compass. 4:322-330
Objectives: This study aimed to investigate the anti-PD-1 inhibitor pembrolizumab as a potential agent for use in non-muscle-invasive bladder cancer (NMIBC) by conducting a Phase 1 safety run-in study to assess the safety and tolerability of intraves
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ad107e8430b9d020e50050bd544b8bc
https://doi.org/10.1002/bco2.220
https://doi.org/10.1002/bco2.220
Autor:
Barnkob MB; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK. mike.bogetofte.barnkob@rsyd.dk.; Centre for Cellular Immunotherapy of Haematological Cancer Odense (CITCO), Department of Clinical Immunology, Odense University Hospital, University of Southern Denmark, Odense, Denmark. mike.bogetofte.barnkob@rsyd.dk., Michaels YS; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Paul Albrechtsen Research Institute, CancerCare Manitoba, 675 Mcdermot Ave, Winnipeg, MB, R3E 0V9, Canada.; Department of Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, University of Manitoba, Bannatyne Ave, Winnipeg, MB, R3E 3N4, Canada., André V; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK., Macklin PS; Nuffield Department of Medicine, University of Oxford, Nuffield Department of Medicine Research Building, Roosevelt Drive, Oxford, OX3 7FZ, UK., Gileadi U; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK., Valvo S; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK., Rei M; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Kulicke C; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, OR, US., Chen JL; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK., Jain V; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK., Woodcock VK; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK., Colin-York H; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK., Hadjinicolaou AV; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Division of Gastroenterology & Hepatology, Department of Medicine, Cambridge University Hospitals, University of Cambridge, Cambridge, England.; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, England., Kong Y; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK., Mayya V; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK., Mazet JM; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK., Mead GJ; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK., Bull JA; Wolfson Centre for Mathematical Biology, Mathematical Institute, University of Oxford, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, UK., Rijal P; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK., Pugh CW; Nuffield Department of Medicine, University of Oxford, Nuffield Department of Medicine Research Building, Roosevelt Drive, Oxford, OX3 7FZ, UK., Townsend AR; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK., Gérard A; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK., Olsen LR; Department of Health Technology, Technical University of Denmark, Ørsteds Plads, Building 345C, 2800 Kgs, Lyngby, Denmark., Fritzsche M; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK., Fulga TA; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK., Dustin ML; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK., Jones EY; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK. yvonne@strubi.ox.ac.uk., Cerundolo V; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.
Publikováno v:
Nature communications [Nat Commun] 2024 Apr 24; Vol. 15 (1), pp. 3448. Date of Electronic Publication: 2024 Apr 24.
Autor:
Barnkob MB; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK. mike.bogetofte.barnkob@rsyd.dk.; Centre for Cellular Immunotherapy of Haematological Cancer Odense (CITCO), Department of Clinical Immunology, Odense University Hospital, University of Southern Denmark, Odense, Denmark. mike.bogetofte.barnkob@rsyd.dk., Michaels YS; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Paul Albrechtsen Research Institute, CancerCare Manitoba, 675 Mcdermot Ave, Winnipeg, MB, R3E 0V9, Canada.; Department of Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, University of Manitoba, Bannatyne Ave, Winnipeg, MB, R3E 3N4, Canada., André V; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK., Macklin PS; Nuffield Department of Medicine, University of Oxford, Nuffield Department of Medicine Research Building, Roosevelt Drive, Oxford, OX3 7FZ, UK., Gileadi U; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK., Valvo S; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK., Rei M; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Kulicke C; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, OR, US., Chen JL; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK., Jain V; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK., Woodcock VK; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK., Colin-York H; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK., Hadjinicolaou AV; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Division of Gastroenterology & Hepatology, Department of Medicine, Cambridge University Hospitals, University of Cambridge, Cambridge, England.; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, England., Kong Y; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK., Mayya V; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK., Mazet JM; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK., Mead GJ; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK., Bull JA; Wolfson Centre for Mathematical Biology, Mathematical Institute, University of Oxford, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, UK., Rijal P; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK., Pugh CW; Nuffield Department of Medicine, University of Oxford, Nuffield Department of Medicine Research Building, Roosevelt Drive, Oxford, OX3 7FZ, UK., Townsend AR; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK., Gérard A; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK., Olsen LR; Department of Health Technology, Technical University of Denmark, Ørsteds Plads, Building 345C, 2800 Kgs, Lyngby, Denmark., Fritzsche M; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK., Fulga TA; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK., Dustin ML; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Dr, Oxford, OX3 7FY, UK., Jones EY; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK. yvonne@strubi.ox.ac.uk., Cerundolo V; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford, OX3 9DS, UK.
Publikováno v:
Nature communications [Nat Commun] 2024 Apr 12; Vol. 15 (1), pp. 3173. Date of Electronic Publication: 2024 Apr 12.
Autor:
Taylor CA; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK., Watson RA; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK.; Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK., Tong O; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK., Ye W; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK., Nassiri I; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK., Gilchrist JJ; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Paediatrics, University of Oxford, Oxford, UK.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK., de Los Aires AV; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK., Sharma PK; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK., Koturan S; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK., Cooper RA; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK., Woodcock VK; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK.; Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK., Jungkurth E; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK., Shine B; Department of Clinical Biochemistry, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK., Coupe N; Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK., Payne MJ; Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK., Church DN; Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK., Naranbhai V; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Center for the AIDS Programme of Research in South Africa, Durban, South Africa., Groha S; Department of Medical Oncology, Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard & MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Emery P; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.; National Institute for Health Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Mankia K; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.; National Institute for Health Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard & MIT, Cambridge, MA, USA., Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard & MIT, Cambridge, MA, USA.; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Middleton MR; Department of Oncology, University of Oxford, Oxford, UK.; Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Gusev A; Department of Medical Oncology, Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard & MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA., Fairfax BP; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK. benjamin.fairfax@oncology.ox.ac.uk.; Department of Oncology, University of Oxford, Oxford, UK. benjamin.fairfax@oncology.ox.ac.uk.; Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK. benjamin.fairfax@oncology.ox.ac.uk.; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. benjamin.fairfax@oncology.ox.ac.uk.
Publikováno v:
Nature medicine [Nat Med] 2022 Dec; Vol. 28 (12), pp. 2592-2600. Date of Electronic Publication: 2022 Dec 16.
Autor:
Zarifkar P; Department of Nuclear Medicine and PET, Aarhus University Hospital, Aarhus, Denmark. Electronic address: pardis.zarifkar@post.au.dk., Kamath A; Faculty of Medicine, University of Oxford, Medical Sciences Divisional Office, University of Oxford, John Radcliffe Hospital, Oxford, UK., Robinson C; Faculty of Medicine, University of Oxford, Medical Sciences Divisional Office, University of Oxford, John Radcliffe Hospital, Oxford, UK., Morgulchik N; Imperial College London, Department of Chemistry, Molecular Sciences Research Hub, London, UK., Shah SFH; School of Clinical Medicine, University of Cambridge, Cambridge, UK., Cheng TKM; School of Clinical Medicine, University of Cambridge, Cambridge, UK., Dominic C; Barts and the London School of Medicine, Queen Mary University of London, London, UK., Fehintola AO; College of Medicine, University of Ibadan, Ibadan, Nigeria., Bhalla G; Barts and the London School of Medicine, Queen Mary University of London, London, UK., Ahillan T; University College London Medical School, London, UK., Mourgue d'Algue L; University College London, Faculty of Life Sciences, London, UK., Lee J; Nuffield Department of Primary Care Health Sciences, Oxford University, Oxford, UK., Pareek A; Department of Radiology Stanford University School of Medicine, Stanford, California, USA., Carey M; Department of Palliative Care Oxford University Hospitals NHS Foundation Trust, Sobell House Hospice, Churchill Hospital, Oxford, UK., Hughes DJ; Department of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK., Miller M; Department of Palliative Care Oxford University Hospitals NHS Foundation Trust, Sobell House Hospice, Churchill Hospital, Oxford, UK., Woodcock VK; Department of Oncology, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford, UK., Shrotri M; London School of Hygiene & Tropical Medicine, London, UK.
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2021 Mar; Vol. 33 (3), pp. e180-e191. Date of Electronic Publication: 2020 Nov 19.
Autor:
Middleton MR; Department of Oncology, Medical Sciences Division, University of Oxford, Headington, Oxford, United Kingdom. mark.middleton@oncology.ox.ac.uk., McAlpine C; Immunocore Ltd, Abingdon, Oxford, United Kingdom., Woodcock VK; Department of Oncology, Medical Sciences Division, University of Oxford, Headington, Oxford, United Kingdom., Corrie P; Cambridge University Hospitals, NHS Foundation Trust, Cambridge, United Kingdom., Infante JR; Janssen, Philadelphia, Pennsylvania., Steven NM; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Evans TRJ; Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom., Anthoney A; Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom., Shoushtari AN; Memorial Sloan Kettering Cancer Center, New York, New York., Hamid O; Immunooncology, The Angeles Clinic and Research Institute, Los Angeles, California., Gupta A; Department of Oncology, Medical Sciences Division, University of Oxford, Headington, Oxford, United Kingdom., Vardeu A; Immunocore Ltd, Abingdon, Oxford, United Kingdom., Leach E; Immunocore Ltd, Abingdon, Oxford, United Kingdom., Naidoo R; Immunocore Ltd, Abingdon, Oxford, United Kingdom., Stanhope S; Immunocore Ltd, Abingdon, Oxford, United Kingdom., Lewis S; Immunocore Ltd, Abingdon, Oxford, United Kingdom., Hurst J; Immunocore Ltd, Abingdon, Oxford, United Kingdom., O'Kelly I; Immunocore Ltd, Abingdon, Oxford, United Kingdom., Sznol M; Yale Cancer Center, Yale School of Medicine, Yale, Connecticut.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Nov 15; Vol. 26 (22), pp. 5869-5878. Date of Electronic Publication: 2020 Aug 18.
Autor:
Woodcock VK; University of Oxford Department of Oncology, Churchill Hospital, Old Road, Oxford OX3 7LJ, UK., Clive S; Edinburgh Cancer Centre, Western General Hospital, Edinburgh EH4 2XU, UK., Wilson RH; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Lisburn Road, Belfast BT9 7AE, Northern Ireland, UK., Coyle VM; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Lisburn Road, Belfast BT9 7AE, Northern Ireland, UK., Stratford MRL; Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK., Folkes LK; Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK., Eastell R; Academic Unit of Bone Metabolism, University of Sheffield, Sheffield S10 2TN, UK., Barton C; Cancer Research UK Centre for Drug Development, Cancer Research UK, Angel Building, 407 St. John Street, London EC1V 4AD, UK., Jones P; Cancer Research UK Centre for Drug Development, Cancer Research UK, Angel Building, 407 St. John Street, London EC1V 4AD, UK., Kazmi-Stokes S; Cancer Research UK Centre for Drug Development, Cancer Research UK, Angel Building, 407 St. John Street, London EC1V 4AD, UK., Turner H; Cancer Research UK Centre for Drug Development, Cancer Research UK, Angel Building, 407 St. John Street, London EC1V 4AD, UK., Halford S; Cancer Research UK Centre for Drug Development, Cancer Research UK, Angel Building, 407 St. John Street, London EC1V 4AD, UK., Harris AL; University of Oxford Department of Oncology, Churchill Hospital, Old Road, Oxford OX3 7LJ, UK., Middleton MR; University of Oxford Department of Oncology, Churchill Hospital, Old Road, Oxford OX3 7LJ, UK.; National Institute for Health Research Oxford Biomedical Research Centre, Oxford OX3 7LE, UK.
Publikováno v:
British journal of cancer [Br J Cancer] 2018 Mar 20; Vol. 118 (6), pp. 770-776. Date of Electronic Publication: 2018 Feb 13.
Autor:
Fayed HE; Department of Medicine, Oxford University Hospitals, Banbury, UK., Woodcock VK, Grayez J
Publikováno v:
BMJ case reports [BMJ Case Rep] 2013 May 15; Vol. 2013. Date of Electronic Publication: 2013 May 15.